Press Releases

Emmaus Life Sciences Reports Preliminary Gross Sales for the Three Months Ended September 30, 2019October 11, 2019

Company Reports Highest Gross Sales Month of 2019 and Total Gross Sales of $7.0 Achieved in the Third Quarter.

Read More

Emmaus Life Sciences Granted Patent in India for use of Pharmaceutical-grade L-glutamine in Treating DiverticulosisOctober 09, 2019

Issuance by the Indian Patent Office Further Bolsters Emmaus’ International Intellectual Property Portfolio

Read More

Emmaus Life Sciences Announces its Common Stock to Begin Trading on OTCQB September 26September 26, 2019

Emmaus approved to have its common stock trade on the OTCQB marketplace.

Read More

Emmaus Life Sciences Reinforces Positive Outcomes of Endari® Clinical Trials, Including Efficacy Findings That Led to FDA ApprovalSeptember 24, 2019

Summary review of the clinical trials and efficacy findings for Endari.

Read More

Emmaus Life Sciences Announces Withdrawal of Marketing Authorization Application to European Medicines AgencySeptember 19, 2019

Emmaus Life Sciences to withdraw MAA

Read More

Previous
1
...
16
17
18
19
20
21
22
...
37
Next